Accession Agreement to the Shareholders’ Agreement relating to CureVac N.V.Accession Agreement • May 5th, 2022 • Dievini Hopp BioTech Holding GmbH & Co KG • Pharmaceutical preparations
JOINT FILING STATEMENTJoint Filing Agreement • May 5th, 2022 • Dievini Hopp BioTech Holding GmbH & Co KG • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common shares of CureVac N.V. and further agree that this Joint Filing Agreement be included as an exhibit to such joint filing.
